Cargando…

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies

OBJECTIVES: To define a series of clinical trial transparency measures and apply them to large pharmaceutical and biotechnology companies and their 2014 FDA-approved drugs. DESIGN: Cross-sectional descriptive analysis of all clinical trials supporting 2014 Food and Drugs Administration (FDA)-approve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Jennifer E, Wilenzick, Marc, Ritcey, Nolan, Ross, Joseph S, Mello, Michelle M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Ethics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728266/ https://www.ncbi.nlm.nih.gov/pubmed/29208616 http://dx.doi.org/10.1136/bmjopen-2017-017917

Ejemplares similares

Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis
por: Axson, Sydney A, et al.
Publicado: (2021)

Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices
por: Miller, Jennifer, et al.
Publicado: (2019)

Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
por: Miller, Jennifer E, et al.
Publicado: (2015)

A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa
por: Limaye, Dnyanesh, et al.
Publicado: (2015)

Values in breast cancer screening: an empirical study with Australian experts
por: Parker, Lisa, et al.
Publicado: (2015)

Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study
por: Pokorny, Adrian M J, et al.
Publicado: (2023)

Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
por: Ozaki, Akihiko, et al.
Publicado: (2019)

Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study
por: Behdarvand, Behrad, et al.
Publicado: (2019)

‘Lines in the sand’: an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders
por: Parker, Lisa, et al.
Publicado: (2021)

2052: Empirical assessment of a theatrical performance on attitudes and behavior intentions toward research: The informed consent play
por: Rothwell, Erin, et al.
Publicado: (2018)

Moving towards a better path? A mixed-method examination of China’s reforms to remedy medical corruption from pharmaceutical firms
por: Shi, Jianwei, et al.
Publicado: (2018)

Monitoring of approved studies: A difficult tightrope walk by Ethics Committees
por: Davis, Sanish
Publicado: (2018)

Current Experience of Central versus Local Ethics Approval in Multicentre Studies
por: Watling, M I L, et al.
Publicado: (1993)

Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers
por: Shearman, Kirstie, et al.
Publicado: (2022)

Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees
por: Li, Rebecca H, et al.
Publicado: (2016)

Responsible research and innovation: A manifesto for empirical ethics?
por: Gardner, John, et al.
Publicado: (2015)

IEEN workshop report: Professionalism in interdisciplinary and empirical bioethics
por: Owens, John, et al.
Publicado: (2014)

Empirical and philosophical analysis of physicians’ judgments of medical indications
por: Björk, Joar, et al.
Publicado: (2016)

IEEN workshop report: Teaching and learning in interdisciplinary and empirical ethics
por: Ives, Jonathan, et al.
Publicado: (2013)

What potential research participants want to know about research: a systematic review
por: Kirkby, Helen Michelle, et al.
Publicado: (2012)

Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration
por: Modi, Natansh D., et al.
Publicado: (2022)

Do protocols for new randomised trials take previous similar trials into account? Cohort study of contemporary trial protocols
por: Paludan-Müller, Asger Sand, et al.
Publicado: (2019)

Bioethics training programmes for Africa: evaluating professional and bioethics-related achievements of African trainees after a decade of Fogarty NIH investment
por: Kass, Nancy E, et al.
Publicado: (2016)

2030: “Understandable to the subject”: Plain language IRB informed consents
por: Moore, Tina, et al.
Publicado: (2018)

Legislation and Policy Recommendations on Organ and Tissue Donation and Transplantation From an International Consensus Forum
por: Toews, Maeghan, et al.
Publicado: (2023)

Ethical frameworks in clinical research processes during COVID-19: a scoping review
por: Kasherman, Lawrence, et al.
Publicado: (2021)

Attitudes on cost-effectiveness and equity: a cross-sectional study examining the viewpoints of medical professionals
por: Li, David G, et al.
Publicado: (2017)

Patients’ and public views and attitudes towards the sharing of health data for research: a narrative review of the empirical evidence
por: Kalkman, Shona, et al.
Publicado: (2022)

Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study
por: Chappuy, Hélène, et al.
Publicado: (2013)

The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitis
por: Lawrence, David S, et al.
Publicado: (2021)

Prevalence and forms of gender discrimination and sexual harassment among medical students and physicians in French-speaking Switzerland: a survey
por: Najjar, Iris, et al.
Publicado: (2022)

Deceit and Transparency in Placebo Research
por: Justman, Stewart
Publicado: (2013)

Fraud and Malpractice in the Context of Clinical Research: Summary of a Report Prepared by a Working Party of the Medical Committee of the Association of the British Pharmaceutical Industry
Publicado: (1993)

Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
por: Miller, Jennifer E., et al.
Publicado: (2021)

Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
por: Rasekh, Hamid Reza, et al.
Publicado: (2012)

“Eugenics talk” and the language of bioethics
por: Wilkinson, S
Publicado: (2008)

The Nuremberg Code–A critique
por: Ghooi, Ravindra B.
Publicado: (2011)

Ethical challenges in fetal surgery
por: Smajdor, Anna
Publicado: (2010)

Ethics committees in India: Facing the challenges!
por: Kadam, Rashmi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9q7v200rf3foqncbnm5hnm432s